Shares of Proteome Sciences plc (LON:PRM – Get Free Report) rose 9% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). Approximately 967,070 shares traded hands during mid-day trading, an increase of 496% from the average daily volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Performance
The firm has a market capitalization of £9.65 million, a PE ratio of -327.00 and a beta of 0.07. The business’s fifty day simple moving average is GBX 2.73 and its 200-day simple moving average is GBX 3.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- 3 Monster Growth Stocks to Buy Now
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is a Low P/E Ratio and What Does it Tell Investors?
- 2 Drone Stocks Surging from Increased Media Attention
- Learn Technical Analysis Skills to Master the Stock Market
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
